The first preclinical and clinical PET imaging studies suggested an application of TSPO imaging in clinical practice [9, 10], but during the 20 years that followed, research almost exclusively focused on gliomas despite the great variety, heterogeneity and complexity of tumours of the central nervous system (CNS). The gene discussed is TSPO; the disease is central nervous system cancer.